tm logo

Monitor this mark

View On USPTO

XOLAIR
Live/Registered
REGISTERED AND RENEWED

on 30 Mar 2016

Last Applicant/ Owned by

NOVARTIS AG

CH-4002

Basel

CH

Serial Number

78296612 filed on 05th Sep 2003

Registration Number

3086141 registered on 25th Apr 2006

in the Principal Register

Correspondent Address

MAURY M. TEPPER III

MAURY M. TEPPER III

3724 Benson Drive

Raleigh NC 27609

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XOLAIR

Pharmaceutical preparations for the treatment of IgE-mediated disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of IgE-mediated disorders

First Use Date in General

31st Dec 2003

First Use Date in Commerce

31st Dec 2003

Mark Details

Serial Number

No 78296612

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 51653.627.1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
30th Mar 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
30th Mar 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
30th Mar 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
30th Mar 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21st Jan 2016TEAS SECTION 8 & 9 RECEIVED
25th Apr 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09th Sep 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09th Sep 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09th Sep 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Aug 2011TEAS SECTION 8 & 15 RECEIVED